Slagle Financial’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
Slagle Financial's LLY Position: Q2 2026 in Review
Slagle Financial reduced its Eli Lilly (LLY) stake by 0.96% in Q2 2026, selling an estimated $4.09K and leaving 413 shares worth $495K. The position accounts for 0.15% of the portfolio, ranked #84.
Slagle Financial first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. The position peaked at $585K in Q4 2025. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Slagle Financial held 413 shares of Eli Lilly worth $495K as of Q2 2026.
- Slagle Financial sold 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
- Eli Lilly made up 0.15% of Slagle Financial's portfolio in Q2 2026, its #84 holding.
- Slagle Financial first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
- Slagle Financial's Eli Lilly position peaked at $585K in Q4 2025.
- 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Slagle Financial's 13F filing for Q2 2026, filed 29 Jul 2026.